Table 4.
Determination of markers of hAECs by flow cytometry
| Marker | Donor1 | Donor2 | Donor3 | Donor4 | Donor5 | Donor6 |
|---|---|---|---|---|---|---|
| Pan cytokeratin | ++++ | ++++ | ++++ | ++++ | ++++ | ++++ |
| CD73 | +++ | +++ | +++ | +++ | +++ | +++ |
| SSEA-4 | +++ | +++ | +++ | +++ | +++ | +++ |
| CD133 | - | - | - | - | - | - |
| CD90 | - | - | - | - | - | - |
| CD105 | - | - | - | - | - | - |
| CD34 | - | - | - | - | - | - |
| CD45 | - | - | - | - | - | - |
| CD9 | ++ | - | + | + | - | + |
| CD38 | - | - | - | - | - | - |
| HLA-DR | - | - | - | - | - | - |
| Integrin-β2 (CD29) | + | + | + | + | ++ | + |
| Hyaluronic acid receptor (CD44) | - | + | + | + | ++ | + |
| CD56 | -/+ | -/+ | -/+ | -/+ | -/+ | -/+ |
| CD14 | + | ++ | - | + | ++ | - |
| CD3 | - | - | - | - | - | - |
| CD4 | - | - | - | - | - | - |
| CD8 | - | - | - | - | - | - |
–, Not determined; ∓, very low expression (< 10%); +, low expression (10–30%); ++, intermediate expression (30–60%); +++, high expression (60–90%); ++++, very high expression (> 90%)